A Comparison of PET Tracers in Recurrent High-Grade Gliomas: A Systematic Review

Area of Science:

• Neuro-oncology
• Medical Imaging

Background:

• High-grade gliomas (HGGs) present a significant challenge with poor patient prognoses, often necessitating aggressive treatment including surgery and chemoradiotherapy.
• Standard treatments for HGGs can be complicated by tumor characteristics and recurrence, highlighting the need for improved management strategies.
• Current imaging with gadolinium-based contrast-enhanced magnetic resonance imaging (CE-MRI) for recurrent HGGs has limitations in differentiating tumor recurrence from treatment effects and in fully assessing tumor burden.

Approach:

• This review focuses on positron emission tomography (PET) as an advanced imaging modality for recurrent high-grade gliomas.
• It evaluates the efficacy of various PET radiotracers currently in clinical practice for HGG detection and characterization.
• A comparative analysis of different PET tracers is presented to assess their diagnostic performance and clinical utility.

Key Points:

• PET imaging offers potential advantages over CE-MRI in visualizing the full extent of HGGs and distinguishing recurrence from treatment-induced changes.
• Several PET radiotracers are being utilized in clinical settings for HGG management, each with unique properties and applications.
• Identifying optimal PET-based markers is crucial for enhancing the diagnostic accuracy and therapeutic guidance in recurrent HGG cases.

Conclusions:

• PET imaging represents a promising frontier in the management of high-grade gliomas, offering improved visualization and diagnostic capabilities.
• The comparative review of PET radiotracers aims to guide the selection of the most effective imaging agents for recurrent HGGs.
• Further research and clinical implementation of advanced PET techniques are essential for improving outcomes in patients with high-grade gliomas.